tacrolimus orally disintegrating tablet (JW Pharmaceutical)

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug Nametacrolimus orally disintegrating tablet (JW Pharmaceutical)
Drug Alias Nametacrolimustacrolimus orally disintegrating tablet (Choongwae)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcineurin inhibitors
TargetsCalcineurin
Therapy Area/IndicationsGraft vs Host DiseaseImmune System DiseasesMyelodysplastic Syndromes +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJw Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute
Inactive CompaniesJw Pharmaceutical Corp
Active IndicationsGraft vs Host DiseaseMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A